Community/Retail

Health Mart has named Nimesh Jhaveri, MBA, RPh, its new president.

Conducted by the FDA, an analysis follows a series of recalls for some generic versions of the angiotensin II receptor blocker (ARB) medicines containing nitrosamine impurities that do not meet the agency’s safety standards.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

I firmly believe that overall pharmacy knowledge should increase over time.

Because high triglycerides have been associated with an increased risk for CVD, lowering this lab value should also reduce circulatory system risks.

A novel inhaled product was approved in late 2018 for Parkinson Disease.

A public awareness campaign aimed at highlighting the value of the pharmacist has entered its second phase following a successful first phase.

Torrent Pharmaceuticals Limited has expanded its voluntary recall of Losartan potassium tablets USP to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP.

Two lawsuits filed against Walgreens have been settled with the national drug store chain agreeing to pay a total of more than $260 million.

Teva has just unveiled the world's first integrated smart inhaler to the market.

Overall, 3.1% of people in the United States sought treatment from their health care providers for flu-like illness during the week ended January 12, 2019.

Opioid abuse is considered a major public health issue across the country.

Can you solve the pharmaceutical mystery?

One lot of irbesartan and 7 lots of irbesartan and hydrochlorothiazide (HCTZ) combination tablets distributed by Solco Healthcare, a Prinston Pharmaceutical subsidiary are affected.

Students can set themselves apart during rotations, with these tips from a preceptor.

Officials with the FDA have approved Samsung Bioepis’ Ontruzant (trastuzumab-dttb), a biosimilar trastuzumab referencing Herceptin, for the treatment of HER2-positive breast cancer and HER2 overexpressing gastric cancer.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Average total drug spending per hospital admission increased by 18.5% between FY2015 and FY2017.

US citizens are increasingly traveling to international destinations, with Americans making 38 million visits abroad in 2017. Fortunately, pharmacists are well-placed to assist patients in their travel health needs.

Officials with the FDA today approved the first generic version of vigabatrin 500-mg tablets, which is also sold under the brand name Sabril, a medication used to treat complex partial seizures.

This interoperable standard created to exchange information across the health care spectrum is gaining traction across the country.

Measles outbreaks are on the rise globally, and it is considered a public health crisis.

Approximately 94% of widely-used brand-name drugs on the market between 2005 and 2017 more than doubled in price during that time.

CVS Caremark has requested that Walmart continue to fill prescriptions as an in-network participating pharmacy through April 30, 2019.

Meet our #ThankAPharmacist Twitter contest winner, Dr. Lee Golden.

The FDA has approved cabozantinib (Cabometyx, Exelixis) as a treatment for patients with hepatocellular carcinoma (HCC) who previously received sorafenib (Nexavar, Bayer).

The FDA has approved Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) use to include repeat vaccination to help protect against tetanus, diphtheria and pertussis.

Pharmacists are encouraged to discuss vaccination and prevention options with patients.